Fennec Pharmaceuticals (FENC) Change in Account Payables (2014 - 2025)
Fennec Pharmaceuticals posted quarterly Change in Account Payables of -$1.2 million for Q4 2025, down 96.65% year-on-year from -$36.7 million in Q4 2024, and down 1541.33% on a QoQ basis from -$75000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) has 12 years of Change in Account Payables data on file, last reported at -$1.2 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Account Payables fell 96.65% year-over-year to -$1.2 million; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (up 359.59% YoY), and the FY2025 full-year result was $1.4 million, up 359.59% from the prior year.
- Change in Account Payables for Q4 2025 stood at -$1.2 million, down from -$75000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.0 million in Q1 2025 and bottomed at -$1.8 million in Q2 2021.
- The 5-year median for Change in Account Payables is $252500.0 (2022), against an average of $153150.0.
- The widest annual swing landed in 2021, when Change in Account Payables jumped 1387.3%; it then slumped 1405.17% in 2024.
- A 5-year view of Change in Account Payables shows it stood at -$377000.0 in 2021, then soared by 61.8% to -$144000.0 in 2022, then jumped by 681.25% to $837000.0 in 2023, then sank by 174.79% to -$626000.0 in 2024, then tumbled by 96.65% to -$1.2 million in 2025.
- The last three Change in Account Payables figures came in at -$1.2 million (Q4 2025), -$75000.0 (Q3 2025), and $661000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | -1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.23 Mn |
| Dec 31, 2025 | -1.23 Mn |
| Sep 30, 2025 | -75,000.00 |
| Sep 30, 2025 | -75,000.00 |
| Jun 30, 2025 | 661,000.00 |
| Jun 30, 2025 | 661,000.00 |
| Mar 31, 2025 | 2.04 Mn |
| Mar 31, 2025 | 2.04 Mn |
| Dec 31, 2024 | -626,000.00 |
| Dec 31, 2024 | -626,000.00 |
| Sep 30, 2024 | -580,000.00 |
| Sep 30, 2024 | -580,000.00 |
| Jun 30, 2024 | -757,000.00 |
| Jun 30, 2024 | -757,000.00 |
| Mar 31, 2024 | 1.43 Mn |
| Mar 31, 2024 | 1.43 Mn |
| Dec 31, 2023 | 837,000.00 |
| Dec 31, 2023 | 837,000.00 |
| Sep 30, 2023 | -64,000.00 |
| Sep 30, 2023 | -64,000.00 |
| Jun 30, 2023 | 58,000.00 |
| Jun 30, 2023 | 58,000.00 |
| Mar 31, 2023 | 557,000.00 |
| Mar 31, 2023 | 557,000.00 |
| Dec 31, 2022 | -144,000.00 |
| Dec 31, 2022 | -144,000.00 |
| Sep 30, 2022 | 790,000.00 |
| Sep 30, 2022 | 790,000.00 |
| Jun 30, 2022 | 519,000.00 |
| Jun 30, 2022 | 519,000.00 |
| Mar 31, 2022 | 447,000.00 |
| Mar 31, 2022 | 447,000.00 |
| Dec 31, 2021 | -377,000.00 |
| Dec 31, 2021 | -377,000.00 |
| Sep 30, 2021 | 477,000.00 |
| Sep 30, 2021 | 477,000.00 |
| Jun 30, 2021 | -1.83 Mn |
| Jun 30, 2021 | -1.83 Mn |
| Mar 31, 2021 | 937,000.00 |
| Mar 31, 2021 | 937,000.00 |
| Dec 31, 2020 | -1.11 Mn |
| Dec 31, 2020 | -1.11 Mn |
| Sep 30, 2020 | -71,000.00 |
| Sep 30, 2020 | -71,000.00 |
| Jun 30, 2020 | 1.08 Mn |
| Jun 30, 2020 | 1.08 Mn |
| Mar 31, 2020 | 63,000.00 |
| Mar 31, 2020 | 63,000.00 |
| Dec 31, 2019 | 824,000.00 |
| Dec 31, 2019 | 824,000.00 |
| Sep 30, 2019 | -440,000.00 |
| Sep 30, 2019 | -440,000.00 |
| Jun 30, 2019 | -70,000.00 |
| Jun 30, 2019 | -70,000.00 |
| Mar 31, 2019 | 266,000.00 |
| Mar 31, 2019 | 266,000.00 |
| Dec 31, 2018 | -834,000.00 |
| Dec 31, 2018 | -834,000.00 |
| Sep 30, 2018 | 1.16 Mn |
| Sep 30, 2018 | 1.16 Mn |
| Jun 30, 2018 | -324,000.00 |
| Jun 30, 2018 | -324,000.00 |
| Mar 31, 2018 | 178,000.00 |
| Mar 31, 2018 | 178,000.00 |
| Dec 31, 2017 | 363,000.00 |
| Dec 31, 2017 | 363,000.00 |
| Sep 30, 2017 | 196,000.00 |
| Sep 30, 2017 | 196,000.00 |
| Jun 30, 2017 | 71,000.00 |
| Jun 30, 2017 | 71,000.00 |
| Mar 31, 2017 | -19,000.00 |
| Mar 31, 2017 | -19,000.00 |
| Dec 31, 2016 | 8,000.00 |
| Dec 31, 2016 | 8,000.00 |
| Sep 30, 2016 | -110,000.00 |
| Sep 30, 2016 | -110,000.00 |
| Jun 30, 2016 | 120,000.00 |
| Jun 30, 2016 | 120,000.00 |
| Mar 31, 2016 | -72,000.00 |
| Mar 31, 2016 | -72,000.00 |
| Dec 31, 2015 | 45,000.00 |
| Dec 31, 2015 | 45,000.00 |
| Sep 30, 2015 | -149,000.00 |
| Sep 30, 2015 | -149,000.00 |
| Jun 30, 2015 | 17,000.00 |
| Jun 30, 2015 | 17,000.00 |
| Mar 31, 2015 | 76,000.00 |
| Mar 31, 2015 | 76,000.00 |
| Dec 31, 2014 | -56,000.00 |
| Dec 31, 2014 | -56,000.00 |
| Sep 30, 2014 | 30,000.00 |
| Sep 30, 2014 | 30,000.00 |
| Jun 30, 2014 | 180,000.00 |
| Jun 30, 2014 | 180,000.00 |
| Mar 31, 2014 | -58,000.00 |
| Mar 31, 2014 | -58,000.00 |